Loading market dashboard
PDS Biotechnology Corporation
PDSBHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
PDS Biotechnology Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $196.92M | $196.92M - $196.92M | $0.00 | $1.51 | 1 |
| Dec 2029 | $93.41M | $93.41M - $93.41M | $0.00 | $0.50 | 1 |
| Dec 2028 | $3.80M | $3.80M - $3.80M | $0.00 | -$0.423 | 2 |
| Dec 2027 | $23.15M | $23.15M - $23.15M | $0.00 | -$0.467 | 2 |
| Dec 2026 | $11.25M | $11.25M - $11.25M | $0.00 | -$0.497 | 2 |
| Dec 2025 | $366.7K | $366.7K - $366.7K | $0.00 | -$0.80 | 2 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.11 | 0 |